FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC. The approval is related to changes to the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Vasospastic Angina

Drugs mentioned

• NORVASC (amlodipine besylate)

Snippet

SUPPL AP for NORVASC (AMLODIPINE BESYLATE)